BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 33283729)

  • 1. [Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome].
    Zhao WS; Zhang YT; Jiang QL; Liu QF; Dai M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1977-1984. PubMed ID: 33283729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation.
    Rombaut D; Lefèvre C; Rached T; Bondu S; Letessier A; Mangione RM; Farhat B; Lesieur-Pasquier A; Castillo-Guzman D; Boussaid I; Friedrich C; Tourville A; De Carvalho M; Levavasseur F; Leduc M; Le Gall M; Battault S; Temple M; Houy A; Bouscary D; Willems L; Park S; Raynaud S; Cluzeau T; Clappier E; Fenaux P; Adès L; Margueron R; Wassef M; Alsafadi S; Chapuis N; Kosmider O; Solary E; Constantinou A; Stern MH; Droin N; Palancade B; Miotto B; Chédin F; Fontenay M
    Nat Commun; 2024 Apr; 15(1):3016. PubMed ID: 38589367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes.
    Tinsley-Vance SM; Ali NA; Ball S; Aguirre LE; Jain AG; Hussaini MO; Chan O; Kuykendall A; Sweet K; Lancet J; Padron E; Sallman DA; Komrokji RS
    Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):355-359. PubMed ID: 36813626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia.
    Liu L; Zhang D; Fu Q; Wang J; Yu J; Chen D; Wang F; Guo R; Xie X; Jiang Z; Li Y
    Clin Exp Med; 2023 Dec; 23(8):4473-4482. PubMed ID: 37087521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.
    Biancon G; Joshi P; Zimmer JT; Hunck T; Gao Y; Lessard MD; Courchaine E; Barentine AES; Machyna M; Botti V; Qin A; Gbyli R; Patel A; Song Y; Kiefer L; Viero G; Neuenkirchen N; Lin H; Bewersdorf J; Simon MD; Neugebauer KM; Tebaldi T; Halene S
    Mol Cell; 2022 Mar; 82(6):1107-1122.e7. PubMed ID: 35303483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes.
    Martínez-Valiente C; Garcia-Ruiz C; Rosón B; Liquori A; González-Romero E; Fernández-González R; Gómez-Redondo I; Cervera J; Gutiérrez-Adán A; Sanjuan-Pla A
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia.
    Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
    Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.
    Baranwal A; Gurney M; Basmaci R; Katamesh B; He R; Viswanatha DS; Greipp P; Foran J; Badar T; Murthy H; Yi CA; Palmer J; Mangaonkar AA; Patnaik MM; Litzow MR; Hogan WJ; Begna K; Gangat N; Tefferi A; Al-Kali A; Shah MV; Alkhateeb HB
    Haematologica; 2024 Feb; 109(6):1779-91. PubMed ID: 38299584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus.
    Xu F; Jin J; Guo J; Xu F; Chen J; Liu Q; Song L; Zhang Z; Zhou L; Su J; Xiao C; Zhang Y; Yan M; He Q; Wu D; Chang C; Li X; Wu L
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):71. PubMed ID: 38305890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is new in acute myeloid leukemia classification?
    Park HS
    Blood Res; 2024 Apr; 59(1):15. PubMed ID: 38616211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights.
    Shahrabi S; Khosravi A; Shahjahani M; Rahim F; Saki N
    Oncol Rev; 2016 Oct; 10(2):311. PubMed ID: 28058097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid Predominance in Bone Marrow Biopsies of Acute Myeloid Leukemia Patients after Decitabine Treatment Correlates with Mutation Profile and Complete Remission.
    Tiso F; Hebeda KM; Langemeijer SMC; de Graaf AO; Martens JHA; Koorenhof-Scheele TN; Knops R; Kroeze LI; van der Reijden BA; Jansen JH
    Pathobiology; 2024 Apr; ():1-12. PubMed ID: 38643752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activation.
    Venkatasubramanian M; Schwartz L; Ramachandra N; Bennett J; Subramanian KR; Chen X; Gordon-Mitchell S; Fromowitz A; Pradhan K; Shechter D; Sahu S; Heiser D; Scherle P; Chetal K; Kulkarni A; Myers KC; Weirauch MT; Grimes HL; Starczynowski DT; Verma A; Salomonis N
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53-Mutated Myelodysplastic Syndrome: A Diagnostic Approach in Different Clinical Settings.
    Kaseb H; Crane G; Gibson J
    Genet Test Mol Biomarkers; 2024 May; ():. PubMed ID: 38708593
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].
    Cen YX; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2004-2010. PubMed ID: 33283733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SF3B1 mutant myelodysplastic syndrome: Recent advances.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2
    Todisco G; Creignou M; Gallì A; Guglielmelli P; Rumi E; Roncador M; Rizzo E; Nannya Y; Pietra D; Elena C; Bono E; Molteni E; Rosti V; Catricalá S; Sarchi M; Dimitriou M; Ungerstedt J; Vannucchi AM; Hellström-Lindberg E; Ogawa S; Cazzola M; Malcovati L
    Leukemia; 2021 Aug; 35(8):2371-2381. PubMed ID: 33349666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global spliceosome activity regulates entry into cellular senescence.
    Kwon SM; Min S; Jeoun UW; Sim MS; Jung GH; Hong SM; Jee BA; Woo HG; Lee C; Yoon G
    FASEB J; 2021 Jan; 35(1):e21204. PubMed ID: 33337569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spliceosome Mutations in Uveal Melanoma.
    Nguyen JQN; Drabarek W; Yavuzyigitoglu S; Medico Salsench E; Verdijk RM; Naus NC; de Klein A; Kiliç E; Brosens E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia.
    Chauzeix J; Pastoret C; Donaty L; Gachard N; Fest T; Feuillard J; Rizzo D
    Int J Lab Hematol; 2021 Aug; 43(4):683-692. PubMed ID: 33325634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.